JP2002524491A5 - - Google Patents

Download PDF

Info

Publication number
JP2002524491A5
JP2002524491A5 JP2000569778A JP2000569778A JP2002524491A5 JP 2002524491 A5 JP2002524491 A5 JP 2002524491A5 JP 2000569778 A JP2000569778 A JP 2000569778A JP 2000569778 A JP2000569778 A JP 2000569778A JP 2002524491 A5 JP2002524491 A5 JP 2002524491A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000569778A
Other languages
Japanese (ja)
Other versions
JP2002524491A (ja
Filing date
Publication date
Priority claimed from US09/153,133 external-priority patent/US8333996B2/en
Application filed filed Critical
Publication of JP2002524491A publication Critical patent/JP2002524491A/ja
Publication of JP2002524491A5 publication Critical patent/JP2002524491A5/ja
Pending legal-status Critical Current

Links

JP2000569778A 1998-09-15 1999-09-14 燐酸カルシウム送出ビヒクル及びアジュバント Pending JP2002524491A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/153,133 1998-09-15
US09/153,133 US8333996B2 (en) 1995-05-19 1998-09-15 Calcium phosphate delivery vehicle and adjuvant
PCT/US1999/021182 WO2000015194A1 (en) 1998-09-15 1999-09-14 Calcium phosphate delivery vehicle and adjuvant

Publications (2)

Publication Number Publication Date
JP2002524491A JP2002524491A (ja) 2002-08-06
JP2002524491A5 true JP2002524491A5 (enExample) 2005-12-08

Family

ID=22545915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000569778A Pending JP2002524491A (ja) 1998-09-15 1999-09-14 燐酸カルシウム送出ビヒクル及びアジュバント

Country Status (8)

Country Link
US (1) US8333996B2 (enExample)
EP (1) EP1117381A4 (enExample)
JP (1) JP2002524491A (enExample)
KR (2) KR100756677B1 (enExample)
AU (1) AU763487B2 (enExample)
CA (1) CA2342207A1 (enExample)
NZ (1) NZ510198A (enExample)
WO (1) WO2000015194A1 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
PT1150918E (pt) 1999-02-03 2005-01-31 Biosante Pharmaceuticals Inc Metodo de fabrico de particulas terapeuticas de fosfato de calcio
EP1471034A3 (en) * 1999-02-03 2005-03-02 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
JP4473576B2 (ja) 2001-11-19 2010-06-02 スキール テヒノロギー ゲーエムベーハー 骨誘導性および骨伝導特性を有するデバイス
JP4358741B2 (ja) * 2002-09-10 2009-11-04 スキール テヒノロギー ゲーエムベーハー 低酸素濃度下において骨誘導性タンパク質で被覆された金属インプラント
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
CA2516783A1 (en) * 2003-02-21 2005-02-03 Hasumi Llc (Dba Shukokai International) Human lymphocyte vaccine adjuvant
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
US8221781B2 (en) 2003-04-11 2012-07-17 Etex Corporation Osteoinductive bone material
WO2004098457A1 (en) * 2003-04-30 2004-11-18 Therics, Inc. Bone void filler and method of manufacture
FR2856672A1 (fr) * 2003-06-30 2004-12-31 Rhodia Chimie Sa Plaquettes de phosphate de calcium nanometrique.
FR2857268B1 (fr) * 2003-07-08 2007-09-21 Urodelia Composite injectable pour magnetocytolyse de cellules metastatiques osseuses
RU2363478C2 (ru) * 2003-09-12 2009-08-10 Вайет Инъецируемые стержни из фосфата кальция для доставки остеогенных белков
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
US8124118B2 (en) 2003-10-22 2012-02-28 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery
KR20070002014A (ko) 2004-02-13 2007-01-04 노드 파마수티칼스, 인코포레이티드 치료용 인산칼슘 입자, 그 제조 방법 및 그 이용 방법
US8586090B2 (en) * 2004-10-05 2013-11-19 Albert Einstein College Of Medicine Of Yeshiva University Melanin nanoshells for protection against radiation and electronic pulses
US20090041812A1 (en) * 2004-11-01 2009-02-12 Bell Steve J D Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use
AU2005306857A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
DE602005025682D1 (de) * 2004-11-16 2011-02-10 3M Innovative Properties Co Dentalfüllstoffe und zusammensetzungen mit phosphatsalzen
CN101115459B (zh) * 2004-11-16 2012-03-21 3M创新有限公司 包括含磷表面处理的牙科填料
AU2005306868B2 (en) * 2004-11-16 2011-06-09 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
FR2885525B1 (fr) * 2005-05-13 2009-09-18 Urodelia Sa Medicament notamment anti-cancereux, destine a des traitements par immunotherapie, en particulier autologue
AU2006315629B2 (en) * 2005-11-14 2012-04-19 Biomet 3I, Llc Deposition of discrete nanoparticles on an implant surface
AU2006333978B2 (en) * 2006-01-06 2012-04-19 Cell-Medicine, Inc. Immune adjuvant
US8583208B2 (en) * 2006-02-23 2013-11-12 University Corporation, Kanazawa Institute Of Technology Superconducting magnetism measuring apparatus, biomagnetism measuring apparatus, and sensor cylinder cover and sheet for biomagnetism measuring apparatus
CN101431984B (zh) 2006-03-14 2013-07-10 利德斯股份公司 生物可吸收性的控释组合物
US8017237B2 (en) * 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
WO2008051555A2 (en) 2006-10-24 2008-05-02 Biomet 3I, Llc. Deposition of discrete nanoparticles on a nanostructured surface of an implant
US20100260849A1 (en) * 2007-12-13 2010-10-14 Rusin Richard P Remineralizing compositions and methods
WO2009097218A1 (en) * 2008-01-28 2009-08-06 Biomet 3I, Llc Implant surface with increased hydrophilicity
EP2358651A2 (en) 2008-11-12 2011-08-24 Engqvist, Håkan Hydraulic cements, methods and products
JP2009084292A (ja) * 2008-11-14 2009-04-23 Cell-Medicine Inc 免疫アジュバント
JP5274214B2 (ja) * 2008-11-25 2013-08-28 オリンパス株式会社 癌細胞抑制シート
US8790707B2 (en) * 2008-12-11 2014-07-29 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
BRPI1011188B1 (pt) 2009-05-06 2019-10-15 Laboratory Skin Care, Inc. Composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas
JP5633152B2 (ja) * 2010-02-16 2014-12-03 東ソー株式会社 アジュバント
CN105125323B (zh) 2010-03-10 2017-04-12 奥斯-Q公司 用于修复组织缺损的植入体和方法
US8641418B2 (en) 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
CA2861357C (en) 2011-01-19 2022-08-23 Laboratory Skin Care, Inc. Topical minocycline compositions and methods of using the same
JP5966129B2 (ja) * 2011-01-31 2016-08-10 オリンパス株式会社 免疫賦活剤
JP5990752B2 (ja) * 2011-01-31 2016-09-14 オリンパス株式会社 抗体療法の効果増強剤
WO2012105224A1 (ja) * 2011-01-31 2012-08-09 オリンパス株式会社 ワクチン・アジュバント
US9463046B2 (en) 2011-08-22 2016-10-11 Ossdsign Ab Implants and methods for using such implants to fill holes in bone tissue
US8591645B2 (en) 2011-09-09 2013-11-26 Ossdsign Ab Hydraulic cements with optimized grain size distribution, methods, articles and kits
US20130066327A1 (en) 2011-09-09 2013-03-14 Håkan Engqvist Hydraulic cement compositions with low ph methods, articles and kits
JP5999639B2 (ja) * 2011-11-25 2016-09-28 国立研究開発法人産業技術総合研究所 免疫刺激因子担持微粒子
WO2013094722A1 (ja) * 2011-12-22 2013-06-27 オリンパス株式会社 癌細胞抑制セラミックスおよび癌細胞抑制セラミックスの製造方法、骨腫瘍の治療方法、粒径1~10μmのβリン酸三カルシウム多孔体顆粒の使用
US9131995B2 (en) 2012-03-20 2015-09-15 Biomet 3I, Llc Surface treatment for an implant surface
HK1216085A1 (zh) 2012-12-14 2016-10-14 Ossdsign Ab 形成水泥的组合物、三斜磷钙石水泥、植入物及用於矫正骨缺损的方法
HK1217632A1 (zh) 2013-02-12 2017-01-20 Ossdsign Ab 镶嵌型植人物、试剂盒和用於矫正骨缺损的方法
US10709778B2 (en) * 2013-04-24 2020-07-14 Medizinische Universität Wien Vaccine formulation for ocular immunization
GB201318858D0 (en) * 2013-10-25 2013-12-11 Glaxosmithkline Biolog Sa Calcium fluoride compositions
GB201318862D0 (en) * 2013-10-25 2013-12-11 Glaxosmithkline Biolog Sa Calcium fluoride compositions
CN106999214B (zh) 2014-08-14 2020-03-13 奥斯设计公司 镶嵌式植入物及其制造方法、支撑结构和植入物
JPWO2017047095A1 (ja) * 2015-09-17 2018-08-16 国立研究開発法人医薬基盤・健康・栄養研究所 リン酸カルシウムのワクチンアジュバントとしての生理学的特性の最適化
US12178939B2 (en) 2019-01-31 2024-12-31 Cell-Medicine, Inc. Inorganic salt-protein composite medical instrument
CU20200032A7 (es) * 2020-06-09 2022-01-13 Ct Inmunologia Molecular Composiciones vacunales basadas en nano-partículas de fosfatos de calcio para el tratamiento del cáncer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2967802A (en) 1957-12-02 1961-01-10 Diamond Lab Hydrated calcium phosphate gelantigen composition and method of preparing same
FR1604134A (enExample) 1967-09-26 1971-07-12
FR2181426B1 (enExample) 1972-04-06 1974-12-20 Pasteur Institut
US4016252A (en) 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
FI751633A7 (enExample) * 1974-06-04 1975-12-05 Wellcome Found
DE2965725D1 (en) 1978-07-19 1983-07-28 Patrick Couvreur Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
US5085861A (en) * 1987-03-12 1992-02-04 The Beth Israel Hospital Association Bioerodable implant composition comprising crosslinked biodegradable polyesters
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5290558A (en) * 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
US5462751A (en) * 1990-06-22 1995-10-31 The Regeants Of The University Of California Biological and pharmaceutical agents having a nanomeric biodegradable core
US5782971B1 (en) * 1991-06-28 1999-09-21 Norian Corp Calcium phosphate cements comprising amorophous calcium phosphate
US5728385A (en) * 1993-08-12 1998-03-17 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
US5508342A (en) * 1994-02-01 1996-04-16 The United States Of America As Represented By The Secretary Of Commerce Polymeric amorphous calcium phosphate compositions
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US6117456A (en) 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6541037B1 (en) * 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
JP4260891B2 (ja) 1996-10-16 2009-04-30 エテックス コーポレイション 生体セラミック組成物
US5968253A (en) * 1998-07-31 1999-10-19 Norian Corporation Calcium phosphate cements comprising antimicrobial agents

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enExample)
BE2015C057I2 (enExample)
BE2016C007I2 (enExample)
BE2015C018I2 (enExample)
BE2014C017I2 (enExample)
BE2013C051I2 (enExample)
BE2013C020I2 (enExample)
BE2013C015I2 (enExample)
BE2013C001I2 (enExample)
BE2012C036I2 (enExample)
BE1025464I2 (enExample)
BE2008C046I2 (enExample)
BE2010C011I2 (enExample)
BRPI0017527B8 (enExample)
BE2008C047I2 (enExample)
BE2011C004I2 (enExample)
BRPI0001672A2 (enExample)
BRPI0001542A2 (enExample)
BRPI0012675B8 (enExample)
BRPI0017522A2 (enExample)
BRPI0303609A (enExample)
BRMU7902607U2 (enExample)
BRPI9917761A2 (enExample)
CN3097510S (enExample)
CN3097853S (enExample)